Smith & Nephew SNATS (NYSE:SNN) Stock Rating Lowered by Wall Street Zen

Smith & Nephew SNATS (NYSE:SNN - Get Free Report) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued on Saturday.

Several other equities analysts have also recently weighed in on the stock. Canaccord Genuity Group set a $32.00 target price on shares of Smith & Nephew SNATS in a research note on Friday, April 24th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Smith & Nephew SNATS in a research report on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $34.75.

Smith & Nephew SNATS Stock Down 0.5%

Shares of NYSE SNN opened at $29.90 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.57 and a quick ratio of 1.25. The stock has a 50 day moving average price of $33.05 and a 200 day moving average price of $33.65. Smith & Nephew SNATS has a 52 week low of $27.97 and a 52 week high of $38.79.

Smith & Nephew SNATS (NYSE:SNN - Get Free Report) last posted its quarterly earnings results on Tuesday, February 17th. The medical equipment provider reported $29.55 earnings per share for the quarter. The company had revenue of $1.60 billion for the quarter. Equities analysts forecast that Smith & Nephew SNATS will post 2.29 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Todd Asset Management LLC bought a new stake in shares of Smith & Nephew SNATS during the third quarter worth approximately $26,319,000. Goldman Sachs Group Inc. increased its stake in shares of Smith & Nephew SNATS by 49.2% during the first quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider's stock worth $50,255,000 after purchasing an additional 583,809 shares during the period. Bank of America Corp DE increased its stake in shares of Smith & Nephew SNATS by 139.9% during the third quarter. Bank of America Corp DE now owns 987,274 shares of the medical equipment provider's stock worth $35,828,000 after purchasing an additional 575,666 shares during the period. BNP Paribas Financial Markets lifted its holdings in Smith & Nephew SNATS by 365.1% during the 2nd quarter. BNP Paribas Financial Markets now owns 644,525 shares of the medical equipment provider's stock worth $19,742,000 after purchasing an additional 505,934 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky acquired a new stake in Smith & Nephew SNATS during the 3rd quarter worth approximately $16,501,000. 25.64% of the stock is owned by institutional investors.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.